Collaborations, Competitor News, Data Partnership, Pharma

Illumina and Nashville Biosciences Announce Sequencing Agreement with Amgen

Whole-genome sequencing of 35,000 de-identified, diverse genomic DNA samples will begin this month SAN DIEGO, Jan. 9, 2023 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced an agreement with Amgen, a global biopharmaceutical…

Competitor News, HR

ConcertAI Names Claudio D’Ambrosio, PhD, as its First Chief Revenue Officer

CAMBRIDGE, Mass., Jan. 6, 2023 /PRNewswire/ — ConcertAI, LLC (ConcertAI), a leader in AI Software-as-a-Service (SaaS) technology and Real-world Evidence (RWE) solutions for life sciences and healthcare, today announced the appointment of Claudio D’Ambrosio, PhD, as its first Chief Revenue Officer. Dr. D’Ambrosio, who’s been with ConcertAI since 2020 as the head of biopharma…

Partner and Collaborator News, Product Updates

Palantir Introduces Quality Management System for Life Sciences

DENVER, Jan. 9, 2023 /PRNewswire/ — Palantir Technologies Inc. (“Palantir,”NYSE: PLTR), a leading builder of operating systems for organizations across the healthcare sector, today announced the launch of a fit-for-purpose Quality Management System to help its life sciences customers using the Foundry platform meet GxP requirements. With this new offering, Palantir is now…

Asia-Pacific, Collaborations, Competitor News, Data Partnership, International

BC Platforms Selected as Partner to Deliver key Singapore Population Health Study

ZURICH, Switzerland, Jan. 09, 2023 (GLOBE NEWSWIRE) — BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced it has been selected as the platform of choice to analyse and manage data collected from the Health for Life in Singapore (HELIOS) study, which forms part of…

Partner and Collaborator News, Product Updates

Palantir Introduces Quality Management System for Life Sciences

DENVER, Jan. 9, 2023 /PRNewswire/ — Palantir Technologies Inc. (“Palantir,”NYSE: PLTR), a leading builder of operating systems for organizations across the healthcare sector, today announced the launch of a fit-for-purpose Quality Management System to help its life sciences customers using the Foundry platform meet GxP requirements. With this new offering, Palantir is now…

Competitor News, Fundraising/IPO, Product Updates

Crescendo Health Launches to Improve and Accelerate Clinical Trials By Unlocking Patient Health Data

Crescendo Health’s real-world data platform creates partnerships between researchers and patients to gain greater longitudinal insights into health outcomes from clinical research. Company also raises initial funding from top investors; model proven to work after successful pilot completion with top-three clinical research organization. January 05, 2023 08:00 AM Eastern Standard…

Competitor News, Government/Regulatory, Oncology

FoundationOne®Liquid CDx Receives FDA Approval as a Companion Diagnostic for Rozlytrek® (entrectinib)

Foundation Medicine’s liquid biopsy test can now be used by oncologists to identify more patients with rare mutations within their cancer for whom treatment with Rozlytrek may be appropriate January 04, 2023 12:00 PM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, today…

Academic, Collaborations, Interviews, Marketing

Duke Health Joins with nference to Advance Medical Research and Patient Care

January 04, 2023 08:40 AM Eastern Standard Time DURHAM, N.C.–(BUSINESS WIRE)–Duke Health is building upon its longstanding history of innovative research by joining with nference, a science-first software company, to transform healthcare by making biomedical knowledge computable. Together, we aim to accelerate the discovery of state-of-the-art medicine and deliver solutions…

Collaborations, Competitor News, Data Partnership

Verana Health and Sight Sciences Collaborate on Glaucoma Research Using Curated Real-World Data from the IRIS Registry

Glaucoma Qdata Contains More than 341,000 MIGS Records with Nearly Three Years of Patient Follow-Up SAN FRANCISCO and MENLO PARK Calif., Jan. 4, 2023 /PRNewswire/ — Verana Health®—a digital health company elevating quality in real-world data (RWD)—and Sight Sciences, Inc. (NASDAQ: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’…